Back to Agenda
Session 2: Case Examples of Practical Application in Local Context, Q&A and wrap-up
Session Chair(s)
Priya Bahri, PhD
Senior Lead (Pharmacovigilance and Risk Management Guidance and Policy), European Medicines Agency, Netherlands
Speaker(s)
A member state’s approach to implementing GVP Module XVI Rev 3 –
Krystyna Cegielska-Perun, PhD
Head of the Unit for the Assessment of Safety Documentation , Office for Registration of Medicinal Products, Poland
Localising additional RMM for implementation and decision making across the product lifecycle
Ryan Marshall
Risk Management Director, AstraZeneca, United Kingdom
Have an account?